Clinical Trial Update: CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 pediatric trial evaluating CD7-targeted CAR-T cells for relapsed/refractory CD7-positive T-cell acute lymphoblastic leukemia and lymphoblas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoblastic Lymphoma
• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD7 CAR-T cells (CD7 CAR-T cells)

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma | Phase 1, Phase 2 | Status: RECRUITING